These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Radiofrequency ablation for unresectable tumors of the liver. Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476 [TBL] [Abstract][Full Text] [Related]
10. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned. Choy PY; Koea J; McCall J; Holden A; Osbourne M N Z Med J; 2002 Aug; 115(1159):U128. PubMed ID: 12362172 [TBL] [Abstract][Full Text] [Related]
11. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors. Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804 [TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer. Wang YH; Liu JF; Li F; Li A; Liu Q; Liu DB; Liu DG; Wang YJ Chin Med J (Engl); 2009 Apr; 122(8):889-94. PubMed ID: 19493409 [TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160 [TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491 [TBL] [Abstract][Full Text] [Related]
15. [Radiofrequency ablation of colorectal liver metastases]. Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045 [TBL] [Abstract][Full Text] [Related]
16. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Hawksworth J; Geisinger K; Zagoria R; Kavanagh P; Howerton R; Levine EA; Shen P Am Surg; 2004 Jun; 70(6):512-7. PubMed ID: 15212405 [TBL] [Abstract][Full Text] [Related]
17. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system. Glaiberman CB; Pilgram TK; Brown DB J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905 [TBL] [Abstract][Full Text] [Related]
18. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure? Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300 [TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Veltri A; Sacchetto P; Tosetti I; Pagano E; Fava C; Gandini G Cardiovasc Intervent Radiol; 2008; 31(5):948-56. PubMed ID: 18506519 [TBL] [Abstract][Full Text] [Related]